MOLECULAR BASIS OF INHERITED CANCER SYNDROMES
遗传性癌症综合征的分子基础
基本信息
- 批准号:6357985
- 负责人:
- 金额:$ 27.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-27 至 2001-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mutation of p53, inherited in some individuals with Li-Fraumeni Syndrome (LFS), is a critical event in the elaboration of many tumors of diverse origin. Recent data, however, suggest that other genetic alterations also result in the cancer predisposition typical for LFS. The mapping of this locus should yield insight into other genetic events that lead to the genesis of diverse tumor. In addition, since 82% of LFS patients inheriting mutations of p53 inherit a missense mutation in p53, we have created a mouse model containing an arg to his substitution at amino acid 172 of the endogenous p53 gene. This mutation corresponds to the hot spot mutation at amino acid 175 altered in 6% of human tumors. Comparison of p53 missense and null alleles in the mouse will yield valuable insight into the in vivo differences between p53 mutants. Additional genetic events that may modify the ability of p53 to function are suggested by experiments using another mouse model (CE/J) in which heterozygosity or homozygosity at the p53 locus results in embryo lethality. This modifier of p53, mop 1, will also be mappe4d in this study.
p53基因突变,在某些李-弗劳梅尼综合征(LFS)的个体中遗传,是许多不同起源肿瘤的关键事件。然而,最近的数据表明,其他遗传变异也会导致LFS典型的癌症易感性。这个基因座的定位应该会让我们深入了解导致不同肿瘤发生的其他遗传事件。此外,由于82%的LFS患者遗传突变的p53遗传错义突变的p53,我们已经创建了一个小鼠模型,含有一个精氨酸取代他的氨基酸172的内源性p53基因。该突变对应于在6%的人类肿瘤中改变的氨基酸175处的热点突变。在小鼠中比较p53错义和无效等位基因将产生有价值的洞察到p53突变体之间的体内差异。使用另一种小鼠模型(CE/J)进行的实验表明,可能改变p53功能能力的其他遗传事件,其中p53基因座的杂合性或纯合性导致胚胎致死。在本研究中,p53的修饰物mop 1也将是mappe 4d。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUILLERMINA LOZANO其他文献
GUILLERMINA LOZANO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUILLERMINA LOZANO', 18)}}的其他基金
Role of p53 Missense Mutations on Tumorigenesis in Vivo
p53 错义突变在体内肿瘤发生中的作用
- 批准号:
10097999 - 财政年份:2020
- 资助金额:
$ 27.04万 - 项目类别:
Role of p53 Missense Mutations on Tumorigenesis in Vivo
p53 错义突变在体内肿瘤发生中的作用
- 批准号:
10549823 - 财政年份:2020
- 资助金额:
$ 27.04万 - 项目类别:
Role of p53 Missense Mutations on Tumorigenesis in Vivo
p53 错义突变在体内肿瘤发生中的作用
- 批准号:
9883907 - 财政年份:2020
- 资助金额:
$ 27.04万 - 项目类别:
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas
(PQ4) 组蛋白伴侣 DAXX 突变导致胰腺神经内分泌肿瘤而非导管腺癌
- 批准号:
9171873 - 财政年份:2016
- 资助金额:
$ 27.04万 - 项目类别:
CORE--MUTATION DETECTION & CHARACTERIZATION OF TUMOR SUPPRESSOR GENES
核心——突变检测
- 批准号:
6357989 - 财政年份:2000
- 资助金额:
$ 27.04万 - 项目类别:
CORE--MUTATION DETECTION & CHARACTERIZATION OF TUMOR SUPPRESSOR GENES
核心——突变检测
- 批准号:
6198235 - 财政年份:1999
- 资助金额:
$ 27.04万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 27.04万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 27.04万 - 项目类别:














{{item.name}}会员




